In re Man Machine Interface Technologies LLC’s Empirical Analysis
822 F.3d 1282 · 2016
Citation profile
4 federal appellate ·
Relationships
Applies 28 U.S.C. § 1295 · 35 U.S.C. § 102 · 35 U.S.C. § 103
Relies on Teva Pharm. United States, Inc. v. Sandoz, Inc. · Schering Corporation v. Geneva Pharmaceuticals · In re Baxter International, Inc. · Microsoft Corp. v. Proxyconn, Inc. · In Re Yamamoto
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 7 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“review the Board's ultimate claim constructions de novo and its underlying factual determinations involving extrinsic evidence for substantial evidence.”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.